---
title: "Novo Nordisk drug trials show benefits for weight loss and blood sugar reduction"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/267393462.md"
description: "Danish pharmaceutical company Novo Nordisk AS announced that a mid-stage clinical trial of an experimental drug named Amycretin in patients with type 2 diabetes has yielded positive results, showing significant reductions in both weight and blood sugar levels. The company noted that the weight loss drug candidate has been effective in both pill and injection forms. The news drove the company's stock price up more than 3% in the U.S. market"
datetime: "2025-11-25T16:15:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/267393462.md)
  - [en](https://longbridge.com/en/news/267393462.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/267393462.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/267393462.md) | [English](https://longbridge.com/en/news/267393462.md)


# Novo Nordisk drug trials show benefits for weight loss and blood sugar reduction

Danish pharmaceutical company Novo Nordisk (NVO.US) announced that a mid-stage clinical trial of an experimental drug named Amycretin conducted in patients with type 2 diabetes has yielded positive results, showing significant reductions in both weight and blood sugar levels.

The company noted that the weight loss drug candidate has shown effectiveness in both pill and injection forms. The news propelled the company's stock price to rise over 3% in the U.S. market

### 相關股票

- [Novo Nordisk AS (NVO.US)](https://longbridge.com/zh-HK/quote/NVO.US.md)

## 相關資訊與研究

- [NHS clears Wegovy to reduce risk of heart attack and stroke](https://longbridge.com/zh-HK/news/281323250.md)
- [<![CDATA[Novo Nordisk Launches Multi-Month Subscription Program for Wegovy ]]>](https://longbridge.com/zh-HK/news/281216333.md)
- [Novo Nordisk A/S Approves Board Changes](https://longbridge.com/zh-HK/news/280694583.md)
- [U.K. Healthcare System to Offer Novo Nordisk's Wegovy Shot to 1.2 Million Heart Patients](https://longbridge.com/zh-HK/news/281325320.md)
- [Novo Nordisk Updates Articles of Association and Capital Increase Mandate](https://longbridge.com/zh-HK/news/280807928.md)